MedTrace Logo

The Benefit of UHR-CT: Precision of Repeated Volume Measurements of Pulmonary Nodules

NCT04209972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2019-12-24

No results posted yet for this study

Summary

To assess the variability of semi-automated volume measurements of pulmonary nodules on same-day repeated scans of equal radiation dose from two different CT scanners: One high-end CT scanner with standard spatial resolution (CT1) and one UHRCT scanner (CT2), in patients with known or suspected pulmonary metastases.

Conditions

  • Pulmonary Nodule, Solitary

Interventions

DEVICE

Precision Ultra-High-Resolution CT scanner

Patients will be divided on one of the two CT scanners. This group will be scanned on the Precision CT scanner.

DEVICE

Genesis high-end CT scanner

Patients will be divided on one of the two CT scanners. This group will be scanned on the Aquilion one Genesis.

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Monique Brink, PhD, MD · Radboud University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-11
Primary Completion
2019-07-30
Completion
2019-07-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04209972 on ClinicalTrials.gov